Purpose To use safety and efficacy outcomes following treatment with percutaneous
transluminal angioplasty (PTA) and/or stent placement for thoracic central venous …

Background Symptomatic central venous obstruction (CVO) is sometimes observed in
patients undergoing hemodialysis. Angioplasty is generally performed for salvage purposes …

Objectives A common cause of hemodialysis vascular access dysfunction, a primary cause
of morbidity and mortality in patients undergoing hemodialysis, is central venous stenosis or …

Thoracic central vein obstruction (TCVO) in hemodialysis patients is regularly encountered
by interventional radiologists. When symptomatic, TCVO is often treated with angioplasty …

Objective: The study purpose was to determine the outcomes and factors predictive of
primary stent patency for the treatment of central venous occlusive disease (CVOD) in …

Background Central venous occlusion may occur in hemodialysis patients, resulting in arm
or facial swelling and failure of dialysis access. Endovascular management with balloon …

INTRODUCTION: Central (superior vena cava, brachiocephalic, or subclavian) venous
stenoses are a major impediment to long-term arteriovenous access in the upper …

Objectives: We aim to investigate the results of stenting for central venous occlusions and
stenoses in the hemodialysis patients. Methods: Twenty-nine cases treated with …

Purpose: To compare patency in dialysis patients following different endovascular treatment
of symptomatic central venous stenosis. Materials and Methods: A 10-year retrospective …

Background Endovascular treatment is a first-line treatment for upper thoracic central vein
obstruction (CVO). Few studies using bare venous stents (BVS) in CVO have been …